Beefing up Prostate Cancer Therapy with Performance-Enhancing (Anti-) Steroids

Cancer Cell

Volumn 20, Issue 1, 2011, Pages 7-9

  Nelson, William G ^a   Haffner, Michael C ^a   Yegnasubramanian, Srinivasan ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [3 [4 CYANO 3 (TRIFLUOROMETHYL)PHENYL] 5,5 DIMETHYL 4 OXO 2 THIOXO 1 IMIDAZOLIDINYL] 2 FLUORO N METHYLBENZAMIDE; ABIRATERONE; ABIRATERONE ACETATE; ACID PHOSPHATASE; ALKALINE PHOSPHATASE; ANDROGEN RECEPTOR; BICALUTAMIDE; CORTICOSTEROID; CYPROTERONE ACETATE; CYTOCHROME P450 17; DOCETAXEL; FLUTAMIDE; GONADORELIN DERIVATIVE; NILUTAMIDE; PLACEBO; POTASSIUM; PREDNISONE; PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE;

ANDROGEN DEPRIVATION THERAPY; ANDROGEN SYNTHESIS; ANTINEOPLASTIC ACTIVITY; CANCER CELL; CANCER GROWTH; CANCER SURVIVAL; CASTRATION; ENZYME BLOOD LEVEL; FLUID RETENTION; GENE AMPLIFICATION; GENE CONTROL; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HYPERTENSION; METASTASIS; ORCHIECTOMY; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROSTATE CANCER; SHORT SURVEY; SIDE EFFECT; SIGNAL TRANSDUCTION;

EID: 79960074439     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccr.2011.06.019     Document Type: Short Survey

References (10)

1. de Bono J.S., Logothetis C.J., Molina A., Fizazi K., North S., Chu L., Chi K.N., Jones R.J., Goodman O.B., Saad F., et al. N. Engl. J. Med. 2011, 364:1995-2005. COU-AA-301 Investigators.
2. Haffner M.C., De Marzo A.M., Meeker A.K., Nelson W.G., Yegnasubramanian S. Clin. Cancer Res. 2011, 17:3858-3864.
3. Huggins C., Hodges C.V. Cancer Res. 1941, 1:293-297.
4. Kumar-Sinha C., Tomlins S.A., Chinnaiyan A.M. Nat. Rev. Cancer 2008, 8:497-511.
5. Palanisamy N., Ateeq B., Kalyana-Sundaram S., Pflueger D., Ramnarayanan K., Shankar S., Han B., Cao Q., Cao X., Suleman K., et al. Nat. Med. 2010, 16:793-798.
6. Rathkopf D., Carducci M.A., Morris M.J., Slovin S.F., Eisenberger M.A., Pili R., Denmeade S.R., Kelsen M., Curley T., Halter M., et al. J. Clin. Oncol. 2008, 26:2959-2965.
7. Saylor P.J., Smith M.R. J. Natl. Compr. Canc. Netw. 2010, 8:211-223.
8. Scher H.I., Beer T.M., Higano C.S., Anand A., Taplin M.E., Efstathiou E., Rathkopf D., Shelkey J., Yu E.Y., Alumkal J., et al. Lancet 2010, 375:1437-1446. Prostate Cancer Foundation/Department of Defense Prostate Cancer Clinical Trials Consortium.
9. Scher H.I., Sawyers C.L. J. Clin. Oncol. 2005, 23:8253-8261.
10. Shah R.B., Mehra R., Chinnaiyan A.M., Shen R., Ghosh D., Zhou M., Macvicar G.R., Varambally S., Harwood J., Bismar T.A., et al. Cancer Res. 2004, 64:9209-9216.